Development
Cytokinetics, Incorporated
CYTK
$36.16
-$0.42-1.15%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 614.82M | 539.24M | 565.72M | 663.96M | 782.58M |
| Total Receivables | 1.28M | 2.50M | 985.00K | 1.01M | 147.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 11.94M | 19.68M | 19.49M | 14.06M | 12.46M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 375.00K | 1.60M | -- |
| Total Current Assets | 628.05M | 561.42M | 586.58M | 680.63M | 795.19M |
|
|
|||||
| Total Current Assets | 628.05M | 561.42M | 586.58M | 680.63M | 795.19M |
| Net Property, Plant & Equipment | 147.74M | 155.54M | 158.11M | 160.66M | 163.19M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 8.00M | 8.19M | 8.34M | 8.12M | 9.69M |
| Total Assets | 824.32M | 740.61M | 779.90M | 889.82M | 1.01B |
|
|
|||||
| Total Accounts Payable | 21.51M | 13.80M | 12.56M | 17.36M | 25.61M |
| Total Accrued Expenses | 42.64M | 32.95M | 31.47M | 35.63M | 44.10M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 28.97M | 17.24M | 15.70M | 14.26M | 13.79M |
| Total Finance Division Other Current Liabilities | 9.56M | 13.74M | 5.89M | 7.97M | 1.12M |
| Total Other Current Liabilities | 9.56M | 13.74M | 5.89M | 7.97M | 1.12M |
| Total Current Liabilities | 102.68M | 77.72M | 65.62M | 75.22M | 84.62M |
|
|
|||||
| Total Current Liabilities | 102.68M | 77.72M | 65.62M | 75.22M | 84.62M |
| Long-Term Debt | 607.37M | 609.02M | 609.78M | 610.62M | 609.62M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 120.57M | 122.62M | 124.45M | 126.18M | 126.90M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 380.02M | 370.05M | 313.16M | 306.81M | 301.55M |
| Total Liabilities | 1.21B | 1.18B | 1.11B | 1.12B | 1.12B |
|
|
|||||
| Common Stock & APIC | 1.73B | 1.54B | 1.51B | 1.49B | 1.48B |
| Retained Earnings | -2.11B | -1.98B | -1.85B | -1.72B | -1.59B |
| Treasury Stock & Other | -10.00K | -874.00K | -1.46M | -1.65M | -3.59M |
| Total Common Equity | -386.32M | -438.80M | -333.12M | -229.02M | -107.90M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -386.32M | -438.80M | -333.12M | -229.02M | -107.90M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -386.32M | -438.80M | -333.12M | -229.02M | -107.90M |
|
|
|||||